ReviewFrontiers in digital health2026
Explainable AI in breast cancer ultrasound imaging: current developments and challenges.
Review in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer has been one of the most common causes of cancer mortality in the world, and thus, early and correct diagnosis is crucial in enhancing patient outcomes. The use of ultrasound imaging as a complementary diagnostic tool is very common because it is safe, accessible, and cost-effective, especially in resource-strained environments. The deep learning methods have achieved spectacular success in the past few years in their effort to automate the process of detecting and classifying breast cancer based on ultrasound images. The transparency of these models, however, is not always clear, and this problem is commonly known as the black-box problem, which is a serious obstacle to the implementation of these models in clinical practice. Explainable Artificial Intelligence (XAI) is an emerging technology that opens business opportunities to improve the interpretability and reliability of deep learning models by offering insights into the decision-making process of these models. This mini review will be a summary of the current developments in XAI applied to the ultrasound image of breast cancer, such as saliency-based approaches, model-agnostic methods, and attention mechanisms. Moreover, it outlines some of the most significant obstacles, which include a lack of standardized evaluation metrics, clinical validation, and the fact that it is hard to interpret an explanation of noisy imaging conditions. Lastly, possible future pathways are outlined to close the gap between the currently successful AI systems and their successful application to clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.